Published in Transplantation on August 27, 2001
Treatment of alcoholic liver disease. Dig Dis (2005) 1.10
Liver transplantation for alcoholic liver disease. World J Gastroenterol (2010) 0.91
Donor transmitted and de novo cancer after liver transplantation. World J Gastroenterol (2014) 0.85
Long-term survival after liver transplantation for alcoholic liver disease. World J Gastroenterol (2013) 0.81
Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77
Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther (2012) 0.77
[The alcoholic patient in the daily routine]. Wien Klin Wochenschr (2003) 0.77
Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis. World J Hepatol (2015) 0.76
Treatment of decompensated alcoholic liver disease. Int J Hepatol (2011) 0.76
Perceptions of post-transplant recidivism in liver transplantation for alcoholic liver disease. World J Hepatol (2014) 0.75
Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation. J Korean Med Sci (2017) 0.75
Ohio solid organ transplantation consortium criteria for liver transplantation in patients with alcoholic liver disease. World J Hepatol (2016) 0.75
An Evaluation of the Usefulness of Extracorporeal Liver Support Techniques in Patients Hospitalized in the ICU for Severe Liver Dysfunction Secondary to Alcoholic Liver Disease. Hepat Mon (2016) 0.75
Betel quid chewing leads to the development of unique de novo malignancies in liver transplant recipients, a retrospective single center study in Taiwan. Medicine (Baltimore) (2016) 0.75
Risk Factors and Outcomes of De novo Cancers (Excluding Nonmelanoma Skin Cancer) after Liver Transplantation for Primary Sclerosing Cholangitis. Transplantation (2017) 0.75
Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57
Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet (1998) 6.04
Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med (1996) 4.10
Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut (1997) 3.25
Alcoholic liver disease. Lancet (1995) 2.97
Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology (1996) 2.91
Assessing priorities for allocation of donor liver grafts: survey of public and clinicians. BMJ (1998) 1.88
Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119) Hepatology (1991) 1.78
Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut (1999) 1.66
Orthotopic liver transplantation for alcoholic liver disease. Hepatology (1990) 1.61
A rational approach to liver transplantation for the alcoholic patient. Psychosomatics (1990) 1.47
Orthotopic liver transplantation for alcoholic cirrhosis. JAMA (1988) 1.45
Hepatitis C and alcohol. Hepatology (1997) 1.36
Genetic predisposition to organ-specific endpoints of alcoholism. Alcohol Clin Exp Res (1996) 1.34
Psychiatric outcome in alcoholic liver transplant patients. QJM (1994) 1.26
Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States. Liver Transpl Surg (1997) 1.22
Alcohol and cancer. Recent Dev Alcohol (1998) 1.22
Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology (1994) 1.19
Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study. Hepatology (1997) 1.16
Liver transplantation for alcoholic liver disease in the United States: 1988 to 1995. Liver Transpl Surg (1997) 1.16
Patterns of alcohol consumption after liver transplantation. Gut (1998) 1.15
Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology (1999) 1.14
Nonalcoholic liver disease. Overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med (1979) 1.10
Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol (1995) 1.08
Prediction of abstinence from ethanol in alcoholic recipients following liver transplantation. Hepatology (1997) 1.06
Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation (1999) 1.05
Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre. J Hepatol (1996) 1.05
Long-term follow-up of patients with alcoholic liver disease who underwent hepatic transplantation. Liver Transpl Surg (1997) 1.04
Hepatitis C viral infection in liver transplant recipients. Hepatology (1992) 1.04
Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients. Transplantation (1999) 1.02
Hepatitis C virus recurrence after liver transplantation. Gut (1999) 1.01
Alcoholic liver disease in heterozygotes of mutant and normal aldehyde dehydrogenase-2 genes. Hepatology (1991) 1.00
A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver (1995) 1.00
Relapse after transplantation: European studies. Liver Transpl Surg (1997) 0.99
Liver transplantation for end-stage alcoholic liver disease: an assessment of outcomes. Liver Transpl Surg (1997) 0.98
Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology (1994) 0.98
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. Transplantation (2000) 0.95
Liver retransplantation for alcoholic cirrhosis recurring within a 21-month period. Transpl Int (1996) 0.89
The short-term psychological health of alcoholic and non-alcoholic liver transplant recipients. Alcohol Clin Exp Res (1992) 0.88
Conversion of micronodular cirrhosis into macronodular cirrhosis. Hepatology (1983) 0.88
A transformed view of cyclosporine. Nature (1999) 0.86
Epidemiology of alcoholic liver disease. Baillieres Clin Gastroenterol (1993) 0.83
The inheritance of alcoholic liver disease. Baillieres Clin Gastroenterol (1998) 0.81
Liver transplantation for alcoholic liver disease at King's College Hospital: survival and quality of life. Liver Transpl Surg (1997) 0.81
Liver transplantation for alcoholic liver disease: executive statement and recommendations. Summary of a National Institutes of Health workshop held December 6-7, 1996, Bethesda, Maryland. Liver Transpl Surg (1997) 0.81
Prognostic validity of short-term abstinence in alcoholism. Alcohol Clin Exp Res (1994) 0.80
Assessment and follow-up of alcohol-dependent liver transplantation patients. A clinical cohort. Gen Hosp Psychiatry (1996) 0.80
The importance of cofactors in the histologic progression of minimal and mild chronic hepatitis C. Liver (1997) 0.80
Autoimmune liver diseases. Recurrence after liver transplantation. Surg Clin North Am (1999) 0.80
The importance of the effect of underlying disease on rejection outcomes following orthotopic liver transplantation. Transplantation (1996) 0.79
One center's experience with liver transplantation: alcohol use relapse over the long-term. Liver Transpl Surg (1998) 0.79
Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: referral patterns and transplant outcomes. J Gastroenterol Hepatol (1997) 0.78
Recurrence of alcoholic liver disease after liver transplantation. Liver Transpl Surg (1997) 0.77
Comorbidities of alcoholic liver disease that affect outcome of orthotopic liver transplantation. Liver Transpl Surg (1997) 0.77
Pathology of alcoholic liver disease. Baillieres Clin Gastroenterol (1993) 0.76
Liver biopsy findings in patients with alcoholic liver disease complicated by chronic hepatitis C virus infection. Eur J Gastroenterol Hepatol (1995) 0.76
Liver transplantation for alcoholic liver disease. Baillieres Clin Gastroenterol (1993) 0.76
Hepatocytic globules in end-stage hepatic disease: relationship to alpha1-antitrypsin phenotype. Am J Clin Pathol (1997) 0.76
Transplantation for alcoholic liver disease: a perspective from Europe. Liver Transpl Surg (1998) 0.76
Alcohol injury in the transplanted liver. Liver Transpl Surg (1997) 0.76
Evolution of liver transplantation. Hepatology (1982) 19.54
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
Kidney transplantation under FK 506. JAMA (1990) 7.45
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Liver transplantation (1). N Engl J Med (1989) 4.53
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Implementation of a high-sensitivity Micro-Angiographic Fluoroscope (HS-MAF) for in-vivo endovascular image guided interventions (EIGI) and region-of-interest computed tomography (ROI-CT). Proc SPIE Int Soc Opt Eng (2008) 3.49
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24